Background: Cholangiocarcinoma is the second most common primary liver cancer, and the number of cases of intrahepatic cholangiocarcinoma (ICC) have been steadily increasing worldwide. Although the reasons for this surge are unknown, insulin resistance (IR) could be a risk factor, similar to what has been reported for other cancers. Case Report: We report on 3 cases of ICC arising in subjects sharing IR as an underlying risk factor. Case 1 was an obese and dyslipidemic patient with NAFLD. The second and the third patients were affected by type 2 diabetes. Conclusions: Evidence for a link between IR and onset of cholangiocarcinoma in our patients rests on three lines of evidence: epidemiological, biological, and exclusion of others risk factors. Studies are needed to confirm our hypothesis that IR is a risk factor for the development of ICC.

Is cholangiocarcinoma another complication of insulin resistance: a report of three cases / Michelini, E; Lonardo, A; Ballestri, Stefano; Costantini, M; Caporali, C; Bonati, Me; Bertolotti, Marco; Iori, R; Loria, Paola. - In: METABOLIC SYNDROME AND RELATED DISORDERS. - ISSN 1540-4196. - ELETTRONICO. - 5:(2007), pp. 194-202.

Is cholangiocarcinoma another complication of insulin resistance: a report of three cases.

BALLESTRI, Stefano;BERTOLOTTI, Marco;LORIA, Paola
2007

Abstract

Background: Cholangiocarcinoma is the second most common primary liver cancer, and the number of cases of intrahepatic cholangiocarcinoma (ICC) have been steadily increasing worldwide. Although the reasons for this surge are unknown, insulin resistance (IR) could be a risk factor, similar to what has been reported for other cancers. Case Report: We report on 3 cases of ICC arising in subjects sharing IR as an underlying risk factor. Case 1 was an obese and dyslipidemic patient with NAFLD. The second and the third patients were affected by type 2 diabetes. Conclusions: Evidence for a link between IR and onset of cholangiocarcinoma in our patients rests on three lines of evidence: epidemiological, biological, and exclusion of others risk factors. Studies are needed to confirm our hypothesis that IR is a risk factor for the development of ICC.
5
194
202
Is cholangiocarcinoma another complication of insulin resistance: a report of three cases / Michelini, E; Lonardo, A; Ballestri, Stefano; Costantini, M; Caporali, C; Bonati, Me; Bertolotti, Marco; Iori, R; Loria, Paola. - In: METABOLIC SYNDROME AND RELATED DISORDERS. - ISSN 1540-4196. - ELETTRONICO. - 5:(2007), pp. 194-202.
Michelini, E; Lonardo, A; Ballestri, Stefano; Costantini, M; Caporali, C; Bonati, Me; Bertolotti, Marco; Iori, R; Loria, Paola
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/609542
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? ND
social impact